Mannkind Corporation (MNKD) is a publicly traded Healthcare sector company. As of October 29, 2026, MNKD trades at $3.50 with a market cap of $1.10B and a P/E ratio of -23.18. MNKD moved +2.04% today. Year to date, MNKD is -37.72%; over the trailing twelve months it is -36.82%. Its 52-week range spans $2.23 to $6.51. Analyst consensus is strong buy with an average price target of $7.86. Rallies surfaces MNKD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
8 analysts cover MNKD: 0 strong buy, 7 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $7.86.
| Metric | Value |
|---|---|
| Price | $3.50 |
| Market Cap | $1.10B |
| P/E Ratio | -23.18 |
| EPS | $-0.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.51 |
| 52-Week Low | $2.23 |
| Volume | 1.79M |
| Avg Volume | 0 |
| Revenue (TTM) | $393.63M |
| Net Income | $-43.61M |
| Gross Margin | 89.75% |
8 analysts cover MNKD: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.86.